Sung, H. et al. International most cancers statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 international locations. CA Most cancers J. Clin. 71, 209–249 (2021).
Zali, H., Rezaei-Tavirani, M. & Azodi, M. Gastric most cancers: Prevention, danger components and therapy. Gastroenterol. Hepatol. From Mattress Bench 4, 175 (2011).
Lindblad, M., Rodríguez, L. A. G. & Lagergren, J. Physique mass, tobacco and alcohol and danger of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma amongst women and men in a nested case-control examine. Most cancers Causes Management. 16, 285–294 (2005).
Rhyu, M. G., Park, W. S., Jung, Y. J., Choi, S. W. & Meltzer, S. J. Allelic deletions of MCC/APC and p53 are frequent late occasions in human gastric carcinogenesis. Gastroenterology 106, 1584–1588 (1994).
Van Loon, A. J. M., Goldbohm, R. A. & Van Den Brandt, P. A. Socioeconomic standing and abdomen most cancers incidence in males: Outcomes from The Netherlands cohort examine. J. Epidemiol. Group Well being 52, 166 (1998).
Dadashzadeh, Okay., Peppelenbosch, M. P. & Adamu, A. I. Helicobacter pylori pathogenicity components associated to gastric most cancers. Can. J. Gastroenterol. Hepatol. 2017, 7942489 (2017).
López, M. J. et al. Traits of gastric most cancers all over the world. Crit. Rev. Oncol. Hematol. 181, 103841. https://doi.org/10.1016/J.CRITREVONC.2022.103841 (2022).
Tirado-Hurtado, I. et al. Helicobacter pylori: Historical past and info in Peru. Crit. Rev. Oncol. Hematol. 134, 22–30 (2019).
Rawla, P. & Barsouk, A. Epidemiology of gastric most cancers: International developments, danger components and prevention. Prz. Gastroenterol. 14, 26–38 (2019).
Ang, T. L. & Fock, Okay. M. Medical epidemiology of gastric most cancers. Singapore Med. J. 55, 621–628 (2014).
Yoon, H. & Kim, N. Prognosis and administration of excessive danger group for gastric most cancers. Intestine Liver 9, 5 (2015).
Al-Refaie, W. B. et al. The impression of ethnicity on the presentation and prognosis of sufferers with gastric adenocarcinoma. Outcomes from the nationwide most cancers information base. Most cancers 113, 461–469 (2008).
Sanjeevaiah, A., Cheedella, N., Hester, C. & Porembka, M. R. Gastric most cancers: Latest molecular classification advances, racial disparity, and administration implications. J. Oncol. Pract. 14, 217–224 (2018).
Bonequi, P., Meneses-González, F., Correa, P., Rabkin, C. S. & Camargo, M. C. Danger components for gastric most cancers in Latin America: A meta-analysis. Most cancers Causes Management 24, 217–231 (2013).
Willis, Okay. & Hajizadeh, M. Socioeconomic inequalities in gastric most cancers incidence in Canada: 1992–2010. Acta Oncol. 59, 1333–1337 (2020).
Yusefi, A. R., Lankarani, Okay. B., Bastani, P., Radinmanesh, M. & Kavosi, Z. Danger components for gastric most cancers: A scientific overview. Asian Pac. J. Most cancers Prev. 19, 591 (2018).
Mccavit, T. L. et al. Hospital quantity, hospital instructing standing, affected person socioeconomic standing, and outcomes in sufferers hospitalized with sickle cell illness. Am. J. Hematol. 86, 377–380 (2011).
Walker, G. V. et al. Disparities in stage at prognosis, therapy, and survival in nonelderly grownup sufferers with most cancers in response to insurance coverage standing. J. Clin. Oncol. 32, 3118 (2014).
Engel, L. S. et al. Inhabitants attributable dangers of esophageal and gastric cancers. J. Natl. Most cancers Inst. 95, 1404–1413 (2003).
Gammon, M. D. et al. Tobacco, alcohol, and socioeconomic standing and adenocarcinomas of the esophagus and gastric cardia. J. Natl. Most cancers Inst. 89, 1277–1284 (1997).
Rota, M. et al. Training and gastric most cancers danger—A person participant information meta-analysis within the StoP venture consortium. Int. J. Most cancers. 146, 671–681 (2020).
Elshair, M. et al. Affect of socioeconomic standing and sibling quantity on the prevalence of Helicobacter pylori an infection: A cross-sectional examine in a Japanese inhabitants. Nagoya J. Med. Sci. 84, 374 (2022).
Kuwahara, A. et al. Socioeconomic standing and gastric most cancers survival in Japan. Gastric Most cancers 13, 222–230 (2010).
Wu, C. C. et al. The impact of particular person and neighborhood socioeconomic standing on gastric most cancers survival. PLoS One 9, e89655 (2014).
De La Cruz-Vargas, J. A. et al. Proportion of most cancers circumstances and deaths attributable to doubtlessly modifiable danger components in Peru. BMC Most cancers 24, 477 (2024).
Rajabi, B., Corral, J. C., Hakim, N. & Mulla, Z. D. Descriptive epidemiology of gastric adenocarcinoma within the State of Texas by ethnicity: Hispanic versus White non-Hispanic. Gastric Most cancers. 15, 405–413 (2012).
Wu, X., Chen, V. W., Andrews, P. A., Ruiz, B. & Correa, P. Incidence of esophageal and gastric cancers amongst Hispanics, non-Hispanic Whites and non-Hispanic blacks in the USA: Subsite and histology variations. Most cancers Causes Management 18, 585–593 (2007).
Hess, Okay. et al. Clinicopathologic habits of gastric adenocarcinoma in Hispanic sufferers: Evaluation of a single establishment’s expertise over 15 years. Artic. J. Clin. Oncol. 23, 3094–3103 (2005).
Bautista, M. C. et al. Vital racial disparities exist in noncardia gastric most cancers outcomes amongst Kaiser Permanente’s affected person inhabitants. Dig. Dis. Sci. 60, 984–995 (2015).
Lui, F. H., Tuan, B., Swenson, S. L. & Wong, R. J. Ethnic disparities in gastric most cancers incidence and survival within the USA: An up to date evaluation of 1992–2009 SEER information. Dig. Dis. Sci. 59, 3027–3034 (2014).
Duma, N. et al. Gastric adenocarcinoma: Clinicopathologic variations amongst Hispanics and non-Hispanic whites. A single Establishment’s expertise over 14 years. Ann. Gastroenterol. Q. Publ. Hell. Soc. Gastroenterol. 29, 325 (2016).
Kim, J. et al. Race and ethnicity correlate with survival in sufferers with gastric adenocarcinoma. Ann. Oncol. 21, 152–160 (2010).
Tseng, J. et al. Racial variations in tumor biology and therapy of gastric most cancers in the USA. J. Clin. Oncol. 39, 174. https://doi.org/10.1200/JCO.2021.39.3_suppl (2021).
Most cancers Genome Atlas Analysis Community. Complete molecular characterization of gastric adenocarcinoma. Nature 513, 202–209 (2014).
Wardell, C. P. et al. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J. Hepatol. 68, 959–969 (2018).
Cerrato-Izaguirre, D. et al. Somatic mutational panorama in Mexican sufferers: CDH1 mutations and chr20q13.33 amplifications are related to diffuse-type gastric adenocarcinoma. Int. J. Mol. Sci. 23, 11116. https://doi.org/10.3390/ijms231911116 (2022).
Wang, Okay. et al. Entire-genome sequencing and complete molecular profiling establish new driver mutations in gastric most cancers. Nat. Genet. 46, 573–582. https://doi.org/10.1038/ng.2983 (2014).
Wang, R. et al. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma recognized novel targets and molecular subtypes that predict therapy response. Intestine 69, 18–31 (2020).
Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R. & De Crombrugghe, B. Sox9 is required for cartilage formation. Nat. Genet. 22, 85–89 (1999).
Panda, M., Tripathi, S. Okay. & Biswal, B. Okay. SOX9: An rising driving issue from most cancers development to drug resistance. Biochim. Biophys. Acta – Rev. Most cancers 1875, 188517 (2021).
Fan, Y. et al. Epithelial SOX9 drives development and metastases of gastric adenocarcinoma by selling immunosuppressive tumour microenvironment. Intestine. 72, 624–637 (2023).
Wang, G. et al. Zbtb7a suppresses prostate most cancers by repression of a Sox9-dependent pathway for mobile senescence bypass and tumor invasion. Nat. Genet. 45, 739–746 (2013).
Zhu, H. et al. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung most cancers cells by inhibiting SOX9 regulation of CDKN1A by ubiquitination. Lab. Investig. 102, 1203–1213 (2022).
Chen, J. Q. et al. MicroRNA-520f-3p inhibits proliferation of gastric most cancers cells by way of concentrating on SOX9 and thereby inactivating Wnt signaling. Sci. Stories. 10, 1–10 (2020).
Ye, C. et al. Diabetes causes a number of genetic alterations and downregulates expression of DNA restore genes within the prostate. Lab. Make investments. 91, 1363–1374 (2011).
Tang, C. et al. Weight problems shapes choice for driver mutations in most cancers. medRxiv https://doi.org/10.1101/2024.01.10.24301114 (2024).
Volaco, A., Cavalcanti, A. M., Filho, R. P. & Précoma, D. B. Socioeconomic standing: The lacking hyperlink between weight problems and diabetes mellitus?. Curr. Diabetes Rev. 14, 321–326 (2018).
De Moor, J. S., Grey, S. W., Mitchell, S. A., Klabunde, C. N. & Freedman, A. N. Oncologist confidence in genomic testing and implications for utilizing multimarker tumor panel take a look at in apply. JCO Summary. Oncol. 4, 620–631 (2020).
Ku, G. Y. Subsequent technology sequencing in gastric or gastroesophageal adenocarcinoma. Transl. Gastroenterol. Hepatol. 5, 56 (2020).
Horgan, D. et al. Figuring out the steps required to successfully implement next-generation sequencing in oncology at a nationwide degree in Europe. J. Pers. Med. 12, 72 (2022).
E, A. Cuaderno de investigación de mercados: teoría y práctica. Un enfoque aplicado. (2019). Obtainable at: https://repositorio.ulima.edu.pe/deal with/ulima/5626. Accessed 11 July 2023.
Skidmore, Z. L., Campbell, Okay. M., Cotto, Okay. C., Griffith, M. & Griffith, O. L. Exploring the genomic panorama of most cancers affected person cohorts with GenVisR. Curr. Protoc. 1, e252 (2021).
cBioPortal for Most cancers Genomics. Obtainable at: https://www.cbioportal.org/. Accessed 16 July 2023.
